A detailed history of Steward Partners Investment Advisory, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 400 shares of LXRX stock, worth $304. This represents 0.0% of its overall portfolio holdings.

Number of Shares
400
Holding current value
$304
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.51 - $2.39 $604 - $956
400 New
400 $0
Q4 2020

Feb 11, 2021

SELL
$1.05 - $3.67 $2,730 - $9,542
-2,600 Closed
0 $0
Q2 2019

Jul 25, 2019

BUY
$5.35 - $7.11 $13,909 - $18,486
2,600 New
2,600 $16,000
Q4 2018

Jan 15, 2019

SELL
$6.15 - $10.51 $15,990 - $27,326
-2,600 Closed
0 $0
Q1 2018

Apr 20, 2018

SELL
$7.86 - $11.39 $3,144 - $4,556
-400 Reduced 13.33%
2,600 $22,000
Q4 2017

Jan 19, 2018

BUY
$8.77 - $12.28 $26,310 - $36,840
3,000
3,000 $29,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $143M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.